Discussion Topics
Target Audience
This activity is intended for hematologists, medical oncologists and other healthcare providers involved in the treatment of myelofibrosis.
Learning Objectives
Upon completion of this activity, participants should be able to
CE Credit
A CME credit link will be given to each participant as part of the meeting course materials.
Accreditation Statement
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
Research To Practice designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Unlabeled/Unapproved Uses Notice
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the provider or grantors.
Content Validation and Disclosures
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education and adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of an accredited continuing education activity, including faculty, planners, reviewers and others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest will have been mitigated prior to the commencement of this activity. In addition, all activity content is reviewed by RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.
FACULTY — The following faculty reported relevant financial relationships with ineligible entities:
Dr Bose — Advisory Committees: Blueprint Medicines, Geron Corporation, Karyopharm Therapeutics, PharmaEssentia; Consulting Agreements: AbbVie Inc, Bristol Myers Squibb, Cogent Biosciences, CTI BioPharma, a Sobi Company, Disc Medicine, GSK, Incyte Corporation, Ionis Pharmaceuticals Inc, Jubilant Pharma Limited, Keros Therapeutics, Morphic Therapeutic, MorphoSys, Novartis, Sumitomo Dainippon Pharma Oncology Inc; Contracted Research: Blueprint Medicines, Bristol Myers Squibb, Cogent Biosciences, CTI BioPharma, a Sobi Company, Disc Medicine, Geron Corporation, Incyte Corporation, Ionis Pharmaceuticals Inc, Janssen Biotech Inc, Kartos Therapeutics, Karyopharm Therapeutics, MorphoSys, Sumitomo Dainippon Pharma Oncology Inc, Telios Pharma Inc. Dr Fleischman — Advisory Committees: CTI BioPharma, a Sobi Company, Incyte Corporation; Consulting Agreement: Ionis Pharmaceuticals Inc; Speakers Bureaus: CTI BioPharma, a Sobi Company, GSK, PharmaEssentia. Dr Yacoub — Consulting Agreements: AbbVie Inc, Acceleron Pharma, Apellis, CTI BioPharma, a Sobi Company, Gilead Sciences Inc, Incyte Corporation, Karyopharm Therapeutics, Notable Labs, Novartis, Pfizer Inc, PharmaEssentia, Protagonist Therapeutics, Servier Pharmaceuticals LLC.
MODERATOR — Dr Kuykendall — Advisory Committees: AbbVie Inc, Blueprint Medicines, Bristol Myers Squibb, Cogent Biosciences, CTI BioPharma, a Sobi Company, Incyte Corporation, Karyopharm Therapeutics, PharmaEssentia; Consulting Agreements: AbbVie Inc, Karyopharm Therapeutics, MorphoSys; Contracted Research: Blueprint Medicines, Bristol Myers Squibb, Geron Corporation, Janssen Biotech Inc, Protagonist Therapeutics, MorphoSys; Data and Safety Monitoring Board/Committee: Geron Corporation.
Research To Practice CME Planning Committee Members, Staff and Reviewers — Planners, scientific staff and independent reviewers for Research To Practice have no relevant conflicts of interest to disclose. SupportersManchester Grand Hyatt San Diego
1 Market Place
San Diego, CA 92101
Meeting Room
Seaport E-H (Second Level)
I am a practicing physician, fellow, nurse or other healthcare provider involved in the treatment of cancer.
IN-PERSON RegistrationPlease note, a limited number of seats are available to other/industry professionals on a first come, first served basis.
IN-PERSON RegistrationPlease note, we will stream this event over Zoom. After registering you will receive a separate confirmation from Zoom with the viewing instructions.
REGISTRATION FOR WEBCAST »